Detalles de la búsqueda
1.
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Circulation
; 144(22): 1738-1746, 2021 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649459
2.
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
Stroke
; 52(3): 1065-1068, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504190
3.
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Stroke
; 51(6): 1758-1765, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404035
4.
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
N Engl J Med
; 377(16): 1513-1524, 2017 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844193
5.
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
Eur Heart J
; 40(19): 1553-1562, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30793734
6.
Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
Circulation
; 137(11): 1117-1129, 2018 03 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29101289
7.
Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.
Europace
; 21(6): 879-885, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982849
8.
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study.
Europace
; 20(2): 253-262, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28520924
9.
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Europace
; 18(9): 1308-18, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27335063
10.
Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting.
Thromb J
; 14: 8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27042163
11.
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 Score.
Circ J
; 79(10): 2138-47, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26248573
12.
Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery.
Thromb J
; 13: 37, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26612979
13.
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
J Am Heart Assoc
; 11(11): e023545, 2022 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35656979
14.
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.
JACC Cardiovasc Interv
; 14(7): 768-780, 2021 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826497
15.
Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI.
Am J Med
; 133(11): 1302-1312, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389658
16.
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study.
J Interv Card Electrophysiol
; 55(2): 145-152, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30758702
17.
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
JACC Cardiovasc Interv
; 12(23): 2331-2341, 2019 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806214
18.
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.
JACC Cardiovasc Interv
; 12(16): 1553-1561, 2019 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31439336
19.
Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study.
J Med Econ
; 20(5): 435-442, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27981865
20.
Observational study of dabigatran etexilate 150mg in patients with moderate renal impairment undergoing elective total hip or knee replacement.
Thromb Res
; 143: 103-10, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27208980
Resultados
1 -
20
de 20
1
Próxima >
>>